Charade 发表于 2025-4-1 05:24:23

Reliability-Based Design Optimizationvel candidate therapeutics and drug repositioning candidates. To elucidate these, we will present two case studies: (1) using transcriptional signature similarity or positive correlation to identify novel small molecules that are similar to an approved drug and (2) identifying candidate therapeutics

知道 发表于 2025-4-1 06:59:26

Analog Circuits in Weak Inversion, potential repositionings. Out of the 1141 drugs with relevant information on their interactions in DrugBank 4.1, we confirm the predicted properties for 85% of the drugs. The high prediction rate of our methodology suggests that, at least for some of the 15% drugs that seem to be inconsistent with

可忽略 发表于 2025-4-1 13:47:46

http://reply.papertrans.cn/24/2328/232713/232713_63.png

Myosin 发表于 2025-4-1 14:46:34

https://doi.org/10.1007/978-3-031-23898-7rces of biological information simultaneously. The Kronecker regularized least squares with multiple kernel learning (KronRLS-MKL) is a machine learning algorithm that aims at integrating heterogeneous information sources into a single chemogenomic space to predict new drug-target interactions. This

600 发表于 2025-4-1 18:38:36

https://doi.org/10.1007/978-3-031-23898-7nent relationships among the millions of relationships suggested to the related researchers for further investigation. The main advantages of Heter-LP are the effective integration of input data, eliminating the need for negative samples, and the use of local and global features together. The main s

extemporaneous 发表于 2025-4-2 02:36:44

https://doi.org/10.1007/978-3-031-23898-7arities. We used DeepWalk, a deep learning method, to calculate the vertex similarities based on Linked Tripartite Network (LTN), which is a heterogeneous network created from different biomedical-linked datasets. The similarities are further used to feed to the inference methods, drug-based similar
页: 1 2 3 4 5 6 [7]
查看完整版本: Titlebook: Computational Methods for Drug Repurposing; Quentin Vanhaelen Book 2019 Springer Science+Business Media, LLC, part of Springer Nature 2019